Capecitabine/Mitomycin versus 5-Fluorouracil/Mitomycin in Combination with Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Anal Cancer

Since EXTRA, a non-randomized phase II trial with 31 patients, explored the use of capecitabine, mitomycin and radiation therapy (RT) in the treatment of localized squamous cell carcinoma of the anal canal (SCCAC), this treatment has been considered as an acceptable alternative to infusional 5-FU. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Mineur, Laurent, Vazquez, Léa, Belkacemi, Mohamed, Toullec, Clémence, Bentaleb, Newfel, Boustany, Rania, Plat, Frederi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528380/
https://www.ncbi.nlm.nih.gov/pubmed/37754536
http://dx.doi.org/10.3390/curroncol30090621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528380/
https://www.ncbi.nlm.nih.gov/pubmed/37754536
http://dx.doi.org/10.3390/curroncol30090621

Ejemplares similares